Showing results (681-690 of 690) with videos related to

Sort By:
Pageof 69
You have reached the last page of results.This site can display upto 690 results.
Hepatobiliary Surgery and Nutrition|August 21, 2023
LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitisGang Li, Tian-Lei Zheng, Xiao-Ling Chi, et al.
The Lancet. Oncology|December 9, 2024
Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective studyYu Zhao, Shan Xiong, Qin Ren, et al.
Genome Biology|October 12, 2023
Metagenome-wide analysis uncovers gut microbial signatures and implicates taxon-specific functions in end-stage renal diseasePan Zhang, Xifan Wang, Shenghui Li, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2025
Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 studyZhengbo Song, Ziming Li, Yiping Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2022
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)Zhijie Wang, Lin Wu, Baolan Li, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 29, 2020
Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients With Cirrhosis and Acute DecompensationYan Zhang, Bao-Yan Xu, Xian-Bo Wang, et al.
Cancer Cell|September 10, 2024
Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancerJiachen Xu, Rui Wan, Yiran Cai, et al.
Signal Transduction and Targeted Therapy|December 23, 2024
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trialJia Zhong, Kailun Fei, Lin Wu, et al.
Thoracic Cancer|November 14, 2023
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancerDingzhi Huang, Gen Lin, Qian Chu, et al.
Thoracic Cancer|January 14, 2024
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancerGen Lin, Zhijie Wang, Qian Chu, et al.
Pageof 69